Search

Search Constraints

You searched for: Author/Creator Lazzeroni, Matteo

Search Results

2. Advances and controversies in management of breast ductal carcinoma in situ (DCIS). Issue 4 (April 2022)

3. Benefit of low‐dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS. Issue 9 (19th July 2016)

4. Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches. Issue 5 (20th December 2014)

5. Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series. (April 2019)

6. Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS or pre-invasive disease of the breast. (November 2019)

7. Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer?. Issue 12 (December 2020)

8. Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II Trial. Issue 6 (20th October 2020)

9. Patient‐ versus physician‐reported outcomes in a low‐dose tamoxifen trial in noninvasive breast cancer. Issue 11 (8th October 2021)